HSBC Holdings’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$73.4M Buy
1,166,543
+280,259
+32% +$19.5M 0.04% 407
2025
Q4
$58.9M Sell
886,284
-372,612
-30% -$24.1M 0.03% 453
2025
Q3
$84.4M Buy
1,258,896
+471,906
+60% +$37.3M 0.05% 368
2025
Q2
$68.6M Sell
786,990
-180,088
-19% -$14.1M 0.04% 391
2025
Q1
$65.7M Sell
967,078
-15,729
-2% -$1.28M 0.04% 405
2024
Q4
$76.6M Sell
982,807
-161,991
-14% -$12M 0.04% 379
2024
Q3
$76.8M Sell
1,144,798
-124,212
-10% -$10.2M 0.04% 381
2024
Q2
$143M Buy
1,269,010
+252,824
+25% +$32M 0.09% 211
2024
Q1
$141M Buy
1,016,186
+76,007
+8% +$9.55M 0.1% 201
2023
Q4
$117M Buy
940,179
+20,889
+2% +$2.13M 0.1% 187
2023
Q3
$86M Sell
919,290
-85,614
-9% -$9.65M 0.09% 216
2023
Q2
$129M Buy
1,004,904
+509,766
+103% +$61.7M 0.13% 135
2023
Q1
$57.4M Sell
495,138
-42,217
-8% -$4.73M 0.07% 296
2022
Q4
$60.6M Buy
537,355
+176,974
+49% +$19.4M 0.07% 296
2022
Q3
$29.4M Sell
360,381
-19,143
-5% -$1.62M 0.05% 401
2022
Q2
$28.5M Buy
379,524
+40,768
+12% +$3.72M 0.04% 462
2022
Q1
$43.6M Sell
338,756
-19,064
-5% -$2.09M 0.05% 353
2021
Q4
$48.3M Buy
357,820
+19,756
+6% +$2.84M 0.04% 396
2021
Q3
$46.2M Buy
338,064
+16,764
+5% +$2.11M 0.05% 354
2021
Q2
$34.3M Sell
321,300
-33,440
-9% -$3.21M 0.04% 448
2021
Q1
$31.5M Buy
354,740
+16,044
+5% +$1.51M 0.04% 453
2020
Q4
$31M Buy
338,696
+66,132
+24% +$5.9M 0.04% 428
2020
Q3
$27.9M Buy
272,564
+4,100
+2% +$428K 0.04% 371
2020
Q2
$27.2M Buy
268,464
+158,868
+145% +$14.2M 0.05% 341
2020
Q1
$7.42M Sell
109,596
-33,636
-23% -$2.09M 0.02% 685
2019
Q4
$7.82M Sell
143,232
-2,640
-2% -$125K 0.01% 920
2019
Q3
$5.44M Sell
145,872
-3,512
-2% -$136K 0.01% 1146
2019
Q2
$5.6M Buy
149,384
+67,596
+83% +$2.12M 0.01% 1097
2019
Q1
$2.44M Buy
81,788
+27,868
+52% +$979K ﹤0.01% 1427
2018
Q4
$1.61M Sell
53,920
-74,888
-58% -$2.38M ﹤0.01% 1578
2018
Q3
$4.61M Buy
128,808
+44,400
+53% +$1.38M 0.01% 1160
2018
Q2
$2M Buy
84,408
+71,248
+541% +$1.51M ﹤0.01% 1504
2018
Q1
$244K Sell
13,160
-10,132
-43% -$150K ﹤0.01% 2298
2017
Q4
$334K Sell
23,292
-1,364
-6% -$17.7K ﹤0.01% 1666
2017
Q3
$301K Sell
24,656
-3,164
-11% -$55.9K ﹤0.01% 1944
2017
Q2
$509K Sell
27,820
-18,720
-40% -$346K ﹤0.01% 1690
2017
Q1
$986K Buy
46,540
+7,760
+20% +$151K ﹤0.01% 1417
2016
Q4
$579K Sell
38,780
-207,072
-84% -$3.67M ﹤0.01% 1726
2016
Q3
$5.39M Buy
245,852
+230,076
+1,458% +$5.12M 0.01% 887
2016
Q2
$313K Buy
15,776
+400
+3% +$6.81K ﹤0.01% 1749
2016
Q1
$262K Sell
15,376
-19,068
-55% -$319K ﹤0.01% 1807
2015
Q4
$706K Buy
34,444
+3,804
+12% +$79.2K ﹤0.01% 1571
2015
Q3
$658K Buy
30,640
+1,012
+3% +$22.6K ﹤0.01% 1325
2015
Q2
$593K Buy
29,628
+16,624
+128% +$292K ﹤0.01% 1366
2015
Q1
$202K Buy
+13,004
New +$196K ﹤0.01% 1929

Other funds holding DXCM

HSBC Holdings's DXCM Position: Q1 2026 in Review

HSBC Holdings increased its DexCom (DXCM) stake by 32% in Q1 2026, buying an estimated $19.5M and bringing the position to 1,166,543 shares worth $73.4M. The position accounts for 0.04% of the portfolio, ranked #407.

HSBC Holdings first reported a position in DXCM in Q1 2015 and has held it in 45 quarters since. The position peaked at $143M in Q2 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • HSBC Holdings held 1,166,543 shares of DexCom worth $73.4M as of Q1 2026.
  • HSBC Holdings bought 280,259 DexCom shares in Q1 2026, an estimated $19.5M.
  • DexCom made up 0.04% of HSBC Holdings's portfolio in Q1 2026, its #407 holding.
  • HSBC Holdings first reported a position in DexCom in Q1 2015 and has held it in 45 quarters since.
  • HSBC Holdings's DexCom position peaked at $143M in Q2 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.